Search Results

Dual Roles of Canagliflozin on Cholangiocarcinoma Cell Growth and Enhanced Growth Suppression in Combination with FK866.

• Authors : Taguchi, Daisuke¹ (AUTHOR); Shirakami, Yohei¹ (AUTHOR) ; Sakai, Hiroyasu¹ (AUTHOR)

Subjects: *SODIUM-glucose cotransporter 2 inhibitors; *CELL migration; *CELL growth

• Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 3, p978. 17p.

Record details

Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma.

• Authors : O'Donnell, Conor D. J.¹ (AUTHOR); Majeed, Umair^1,2 (AUTHOR); Rutenberg, Michael S.^2,3 (AUTHOR)

• Source: Current Oncology. Feb2025, Vol. 32 Issue 2, p82. 22p.

Record details

Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma.

• Authors : Zhang, Dai^1,2 (AUTHOR) ; Sun, Bao-Ye^2,3 (AUTHOR); Wu, Jing-Fang^2,3 (AUTHOR)

• Source: Current Oncology. Feb2025, Vol. 32 Issue 2, p56. 14p.

Record details

Preoperative Imaging Assessment and Staging of Perihilar Cholangiocarcinoma: Tips and Pitfalls.

• Authors : Yong, Yu Shan Stephanie¹; Lee, Zhuyi Rebekah¹; Soh, Yock Teck Nicholas¹

• Source: Journal of the Korean Society of Radiology (2951-0805). Jan2025, Vol. 86 Issue 1, p45-67. 23p.

Record details

The Efficacy and Safety of Hepatic Artery Infusion Chemotherapy Combined with Lenvatinib and Programmed Death (PD)-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma: A Retrospective Study.

• Authors : Cai, Yingxiao¹ (AUTHOR); Wen, Wu¹ (AUTHOR); Xia, Yangshuo¹ (AUTHOR)

• Source: Current Oncology. Feb2025, Vol. 32 Issue 2, p87. 15p.

Record details

New Relevant Evidence in Cholangiocarcinoma Biology and Characterization.

• Authors : Porro, Nunzia¹ (AUTHOR) ; Spínola-Lasso, Elena¹ (AUTHOR) ; Pastore, Mirella¹ (AUTHOR)

• Source: Cancers. Dec2024, Vol. 16 Issue 24, p4239. 29p.

Record details

Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for Cholangiocarcinoma.

• Authors : Venkatraman, Simran^1,2 (AUTHOR) ; Balasubramanian, Brinda^1,3 (AUTHOR) ; Kongpracha, Pornparn^4,5,6 (AUTHOR)

• Source: Cancers. Dec2024, Vol. 16 Issue 24, p4197. 20p.

Record details

Circulating miR-18a and miR-532 Levels in Extrahepatic Cholangiocarcinoma.

• Authors : Orzan, Rares Ilie^1,2 (AUTHOR) ; Țigu, Adrian Bogdan³ (AUTHOR); Nechita, Vlad-Ionuț⁴ (AUTHOR)

• Source: Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 20, p6177. 12p.

Record details

Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications.

• Authors : Ricci, Angela Dalia¹ (AUTHOR); Rizzo, Alessandro² (AUTHOR) ; Schirizzi, Annalisa³ (AUTHOR)

• Source: Cancers. Oct2024, Vol. 16 Issue 20, p3542. 18p.

Record details

Tepotinib in Cholangiocarcinoma with MET Amplification: A Case Report.

• Authors : Chen, Yen-Hao (AUTHOR); Huang, Yu-Ting (AUTHOR); Kuo, Fang-Ying (AUTHOR)

• Source: OncoTargets & Therapy. Oct2024, Vol. 17, p857-861. 5p.

Record details